Glioma imaging : physiologic, metabolic, and molecular approaches / Whitney B. Pope, editor.
2020
RC280.B7
Linked e-resources
Linked Resource
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
Glioma imaging : physiologic, metabolic, and molecular approaches / Whitney B. Pope, editor.
ISBN
9783030273590 (electronic book)
3030273598 (electronic book)
9783030273583
3030273598 (electronic book)
9783030273583
Published
Cham : Springer, 2020.
Language
English
Description
1 online resource (xiv, 286 pages) : illustrations.
Item Number
10.1007/978-3-030-27359-0 doi
Call Number
RC280.B7
Dewey Decimal Classification
616.99481
Summary
This book covers physiologic, metabolic and molecular imaging for gliomas. Gliomas are the most common primary brain tumors. Imaging is critical for glioma management because of its ability to noninvasively define the anatomic location and extent of disease. While conventional MRI is used to guide current treatments, multiple studies suggest molecular features of gliomas may be identified with noninvasive imaging, including physiologic MRI and amino acid positron emission tomography (PET). These advanced imaging techniques have the promise to help elucidate underlying tumor biology and provide important information that could be integrated into routine clinical practice. The text outlines current clinical practice including common scenarios in which imaging interpretation impacts patient management. Gaps in knowledge and potential areas of advancement based on the application of more experimental imaging techniques will be discussed. In reviewing this book, readers will learn: current standard imaging methodologies used in clinical practice for patients undergoing treatment for glioma and the implications of emerging treatment modalities including immunotherapy the theoretical basis for advanced imaging techniques including diffusion and perfusion MRI, MR spectroscopy, CEST and amino acid PET the relationship between imaging and molecular/genomic glioma features incorporated in the WHO 2016 classification update and the potential application of machine learning about the recently adopted and FDA approved standard brain tumor protocol for multicenter drug trials of the gaps in knowledge that impede optimal patient management and the cutting edge imaging techniques that could address these deficits.
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed November 18, 2019).
Added Author
Linked Resources
Record Appears in